# A Study of Filgotinib in Korean Participants With Rheumatoid Arthritis

> **NCT06625242** · PHASE4 · COMPLETED · sponsor: **Eisai Korea Inc.** · enrollment: 118 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Filgotinib Maleate

## Key facts

- **NCT ID:** NCT06625242
- **Lead sponsor:** Eisai Korea Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-22
- **Primary completion:** 2026-01-21
- **Final completion:** 2026-02-25
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2026-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06625242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06625242, "A Study of Filgotinib in Korean Participants With Rheumatoid Arthritis". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT06625242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*